Hao-Wen Sim1, Anna K Nowak2, Zarnie Lwin3, Mustafa Khasraw4. 1. NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia; Department of Medical Oncology, The Kinghorn Cancer Centre, Sydney, NSW, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia. 2. Medical School, University of Western Australia, Perth, WA, Australia; ; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia. 3. School of Medicine, University of Queensland, Brisbane, QLD, Australia; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. 4. NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; The Preston Robert Tisch Brain Tumor Center and Duke Center for Cancer Immunotherapy, Duke University, Durham, NC, USA.
Authors: Misa Matsuyama; Mythily Sachchithananthan; Robyn Leonard; Michael Besser; Anna K Nowak; Donna Truran; Claire M Vajdic; John R Zalcberg; Hui K Gan; Craig Gedye; Winny Varikatt; Eng-Siew Koh; Ganessan Kichenadasse; Hao-Wen Sim; Nicholas G Gottardo; Desma Spyridopoulos; Rosalind L Jeffree Journal: Neurooncol Pract Date: 2021-08-31
Authors: Hao-Wen Sim; Kerrie L McDonald; Zarnie Lwin; Elizabeth H Barnes; Mark Rosenthal; Matthew C Foote; Eng-Siew Koh; Michael Back; Helen Wheeler; Erik P Sulman; Michael E Buckland; Lauren Fisher; Robyn Leonard; Merryn Hall; David M Ashley; Sonia Yip; John Simes; Mustafa Khasraw Journal: Neuro Oncol Date: 2021-10-01 Impact factor: 13.029